Opportunity ID: 350331

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-NS-23-032
Funding Opportunity Title: Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 26, 2023
Last Updated Date: Sep 26, 2023
Original Closing Date for Applications: Nov 28, 2023
Current Closing Date for Applications: Nov 28, 2023
Archive Date: Jan 03, 2024
Estimated Total Program Funding:
Award Ceiling: $1,000,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
State governments
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
City or township governments
Special district governments
Native American tribal governments (Federally recognized)
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this initiative is to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers. These Centers promote collaborative basic, translational, and clinical research, and provide important resources that can be used by the national muscular dystrophy research community. The Centers also provide outstanding environments for the training of new scientists electing to pursue careers conducting research in high priority areas of muscular dystrophy. Furthermore, Center investigators participate in community outreach efforts to increase awareness and convey the importance and implications of their research activities to the patient and advocacy communities.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-032.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 350331 Full Announcement-RFA-NS-23-032 -> RFA-NS-23-032-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00283252 Oct 28, 2023 Nov 28, 2023 View

Package 1

Mandatory forms

350331 RR_SF424_5_0-5.0.pdf

350331 PHS398_CoverPageSupplement_5_0-5.0.pdf

350331 RR_OtherProjectInfo_1_4-1.4.pdf

350331 PerformanceSite_4_0-4.0.pdf

350331 RR_KeyPersonExpanded_4_0-4.0.pdf

350331 PHS398_ResearchPlan_5_0-5.0.pdf

350331 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

350331 PHS_Additional_IndirectCosts_2_0-2.0.pdf

350331 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T11:24:28-05:00

Share This Post, Choose Your Platform!

About the Author: